Gefitinib versus cisplatin plus docetaxel in patients with non-small-cell lung cancer harbouring mutations of the epidermal growth factor receptor (WJTOG3405): an open label, randomised phase 3 trial.
T. Mitsudomi, S. Morita, Y. Yatabe, S. Negoro +17 more

